Year-over-year earnings per share growth for the last twelve months: Virax Biolabs Group (VRAX)

Graphic logo of Virax Biolabs Corp (VRAX)

Virax Biolabs Group (VRAX) maintains its diagnostic market position through patents and direct contracts. The GURU.Markets service reports quarterly earnings per share growth, where the parameter value equals 75.00. The company is optimizing the delivery of rapid tests via its warehouse network in the US and Europe, while simultaneously implementing eco-friendly packaging and reducing production energy costs to comply with ESG standards.

VRAX: viraxbiolabs.com Year-over-year earnings per share growth for the last twelve months 04/28/2023 - 11/17/2026

Virax Biolabs Group (VRAX) - metric breakdowns and financial figures

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Initial company analysis:Virax Biolabs Group, VRAX
Manufactured product of Virax Biolabs Corp

Investors utilize this indicator for real-time monitoring of the issuer's financial stability between official reports by assessing the dynamics of net profit per share. This calculation, reflected in the relative quarterly change in EPS, reveals the impact of geopolitical risks and raw material supply chain disruptions on the actual profitability of the Virax Biolabs Group (VRAX) biopharmaceutical business.

Key competitors

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|FLGT (fulgentgenetics.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Standard BioTools Corp|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth XGN (exagen.com)|MDxHealth Inc. - Year-over-year earnings per share growth for the last twelve months|Lucid Diagnostics, Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Prenetics Global Limited PRE|Insight Molecular (IMDX) - Year-over-year earnings per share growth for the last twelve months|TRIB (Trinity Biotech PLC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months ProPhase Labs|Ainos (AIMD) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Biomerica BMRA|CDIO: Year-over-year earnings per share growth for the last 12 months|Onconetix Inc - Quarterly EPS earnings growth|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months